Windtree Therapeutics, Inc. (WINT): History, Ownership, Mission, How It Works & Makes Money

Ever heard of Windtree Therapeutics, Inc. (WINT) and wondered what they're all about? This clinical-stage biotechnology company, established in 1992, is making waves with its innovative therapies for critical conditions and diseases, particularly in pulmonary and cardiovascular areas. But how exactly does Windtree operate, and what's their strategy for generating revenue in a challenging market? Keep reading to find out about Windtree's history, ownership, mission, and how it works and makes money.

Windtree Therapeutics, Inc. (WINT) History

Windtree Therapeutics, Inc. Founding Timeline

Year established

The company was established in 1992.

Original location

The original location is not explicitly mentioned in the provided context. However, the company is currently headquartered in Warrington, PA.

Founding team members

The founding team members are not specified in the provided context.

Initial capital/funding

Information about the initial capital or funding is not available in the provided context.

Windtree Therapeutics, Inc. Evolution Milestones

Windtree Therapeutics, Inc. Transformative Moments

• Strategic Rebranding (2014): The change from Discovery Laboratories to Windtree Therapeutics marked a pivotal shift, signaling a broader therapeutic focus beyond the original surfactant technology. This transformation allowed the company to explore new opportunities and diversify its product pipeline.
• Surfaxin Approval and Launch (2004): The approval and launch of Surfaxin was a transformative moment as it represented the company's first commercial product and validated its surfactant technology. This milestone provided initial revenue and established the company as a player in the respiratory therapeutics market.
• ISTRADIAL's Development and Clinical Progress: The advancement of ISTRADIAL, particularly the positive topline results from the SEASPRING trial, represents a significant potential value inflection point. Success in this area could lead to a new treatment option for acute heart failure and pulmonary hypertension.

For insights into the company's financial standing, consider reading Breaking Down Windtree Therapeutics, Inc. (WINT) Financial Health: Key Insights for Investors.

Windtree Therapeutics, Inc. (WINT) Ownership Structure

Windtree Therapeutics, Inc. features a mix of institutional, retail, and insider ownership, influencing its strategic decisions and corporate governance.

Windtree Therapeutics, Inc.'s Current Status

Windtree Therapeutics, Inc. is a publicly traded company, listed on the financial market under the ticker symbol WINT. This allows anyone to purchase shares in the company.

Windtree Therapeutics, Inc.'s Ownership Breakdown

As Windtree Therapeutics is publicly traded, ownership is distributed among various shareholders. The below table summarizes the approximate ownership breakdown.

Windtree Therapeutics, Inc.'s Leadership

The leadership team is instrumental in guiding the strategic direction of Windtree Therapeutics. Key members include:

• Craig Fraser serves as the President and Chief Executive Officer.
• John Hamill holds the position of Chief Financial Officer.

To gain further insights into Windtree Therapeutics, Inc.’s financial standing, see: Breaking Down Windtree Therapeutics, Inc. (WINT) Financial Health: Key Insights for Investors

Windtree Therapeutics, Inc. (WINT) Mission and Values

Windtree Therapeutics focuses on developing innovative therapies for respiratory diseases. The company is committed to addressing critical unmet needs in respiratory care through scientific excellence and dedication to patient well-being.

Windtree Therapeutics' Core Purpose

Official Mission Statement

Windtree Therapeutics' mission is centered on developing novel therapies to address significant unmet medical needs in respiratory disease, with a focus on acute care settings. This involves:

• Pioneering innovative solutions for respiratory distress.
• Advancing scientific understanding of pulmonary diseases.
• Improving patient outcomes through targeted therapies.

Vision Statement

While a specific vision statement may not be explicitly declared, Windtree Therapeutics' vision can be inferred from their activities and goals:

• To be a leader in the development of innovative respiratory therapies.
• To transform the treatment landscape for patients with acute respiratory conditions.
• To create value for stakeholders through successful development and commercialization of novel products.

Company Slogan/Tagline

Currently, there is no publicly available official slogan or tagline for Windtree Therapeutics. However, considering their focus, a possible implied tagline could be:

• 'Breathing Innovation into Respiratory Care.'
• 'Advancing Respiratory Therapeutics for a Better Life.'
• 'Dedicated to Respiratory Solutions.'

To gain more insights into Windtree Therapeutics' financial stability, consider reading: Breaking Down Windtree Therapeutics, Inc. (WINT) Financial Health: Key Insights for Investors

Windtree Therapeutics, Inc. (WINT) How It Works

Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases. They aim to improve the management of respiratory distress in premature infants and other critically ill patients.

Windtree Therapeutics, Inc.'s Product/Service Portfolio

Windtree Therapeutics, Inc.'s Operational Framework

Windtree Therapeutics focuses on the development and commercialization of innovative therapies for respiratory diseases, particularly targeting premature infants. Their operational framework involves several key steps:

• Research and Development: Windtree conducts research to identify and develop novel surfactant therapies.
• Clinical Trials: They perform clinical trials to evaluate the safety and efficacy of their product candidates.
• Regulatory Approval: Windtree seeks regulatory approval from agencies like the FDA to market their products.
• Manufacturing: They manage the manufacturing process to ensure a consistent supply of their therapies.
• Commercialization: Windtree commercializes their products through sales and marketing efforts, targeting hospitals and healthcare providers.

Windtree Therapeutics, Inc.'s Strategic Advantages

Windtree Therapeutics possesses several strategic advantages that contribute to its market position:

• Novel Technology: Their KL4 surfactant technology represents a novel approach to treating respiratory distress.
• Non-Invasive Delivery: AEROSURF's non-invasive aerosol delivery offers potential advantages over traditional surfactant administration methods.
• Targeted Focus: By focusing on respiratory diseases in premature infants, Windtree addresses a critical unmet medical need.
• Experienced Team: Windtree's management team has experience in drug development and commercialization.

To gain more insights into the values that guide Windtree Therapeutics, explore: Mission Statement, Vision, & Core Values of Windtree Therapeutics, Inc. (WINT).

Windtree Therapeutics, Inc. (WINT) How It Makes Money

Windtree Therapeutics, Inc. primarily makes money through the development and commercialization of novel therapies for respiratory diseases and other unmet medical needs.

Windtree Therapeutics, Inc. Revenue Breakdown

As of April 2025, specific detailed revenue breakdowns for Windtree Therapeutics, Inc. are not comprehensively available in the provided search results. Financial data is often dynamic and can be found in the company's official filings and investor reports. However, based on the company's activities, revenue streams can be generally categorized.

Windtree Therapeutics, Inc. Business Economics

The business economics of Windtree Therapeutics, Inc. are shaped by the following factors:

• Drug Development Costs: Significant investment in research and clinical trials is necessary to bring therapies to market.
• Regulatory Approvals: Securing approvals from regulatory bodies like the FDA is crucial for commercialization.
• Market Competition: The competitive landscape in respiratory therapies affects pricing and market share.
• Intellectual Property: Protecting their innovations through patents is vital for maintaining a competitive edge.

Windtree Therapeutics, Inc. Financial Performance

Windtree Therapeutics, Inc.'s financial performance can be evaluated based on these key points:

• Cash Runway: Monitoring cash reserves is essential to fund ongoing operations and research.
• R&D Expenses: A significant portion of expenses is allocated to research and development activities.
• Partnerships and Collaborations: Strategic alliances can provide additional funding and expertise.
• Stock Performance: Investors often monitor the company's stock performance as an indicator of overall financial health and market confidence.

For more detailed insights into the company's financial standing, consider exploring this resource: Breaking Down Windtree Therapeutics, Inc. (WINT) Financial Health: Key Insights for Investors

Windtree Therapeutics, Inc. (WINT) Market Position & Future Outlook

Windtree Therapeutics is strategically positioned to advance its pipeline of innovative therapies for acute respiratory conditions, with a focus on unmet medical needs. The company's future outlook hinges on the successful development and commercialization of its lead product candidates and strategic management of financial resources. For more information on the company's financial standing, see: Breaking Down Windtree Therapeutics, Inc. (WINT) Financial Health: Key Insights for Investors

Competitive Landscape

Opportunities & Challenges

Industry Position

Windtree Therapeutics holds a unique position in the respiratory therapeutics market due to its proprietary KL4 surfactant technology and AEROSURF® delivery system. However, it competes with larger pharmaceutical companies that have established products and distribution channels. Here are key aspects of its industry standing:

• Niche Focus: The company is focused on developing therapies for acute respiratory conditions, particularly in premature infants.
• Technological Edge: KL4 surfactant technology offers potential advantages over existing surfactant therapies.
• Market Access: Successfully navigating regulatory pathways and securing market access are critical for commercial success.
• Financial Stability: Maintaining sufficient financial resources to fund ongoing research and development efforts is essential.